Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
Saved in:
| Title: | Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE. |
|---|---|
| Authors: | Ferreira JP; Centre d'Investigations Cliniques Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.; UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Blatchford JP; Elderbrook Solutions GmbH, Sky Tower, Borsigstr. 4, D-74321 Bietigheim-Bissingen, Germany on behalf of Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany., Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, CA, USA., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA., Angermann CE; Comprehensive Heart Failure Center Würzburg, Department of Medicine 1, University Hospital Würzburg, Würzburg, Germany., Biegus J; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA., Tromp J; Saw Swee Hock School of Public Health, National University of Singapore, the National University Health System, Singapore, Singapore., Nassif ME; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA., Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA., Comin-Colet J; Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL and CIBERCV, Barcelona, Spain., Mentz RJ; Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, NC, USA., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Nordaby M; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Voors AA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2024 Sep; Vol. 26 (9), pp. 1976-1983. Date of Electronic Publication: 2024 Jul 09. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38980272 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ferreira+JP%22">Ferreira JP</searchLink>; Centre d'Investigations Cliniques Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.; UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Blatchford+JP%22">Blatchford JP</searchLink>; Elderbrook Solutions GmbH, Sky Tower, Borsigstr. 4, D-74321 Bietigheim-Bissingen, Germany on behalf of Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Teerlink+JR%22">Teerlink JR</searchLink>; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kosiborod+MN%22">Kosiborod MN</searchLink>; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Angermann+CE%22">Angermann CE</searchLink>; Comprehensive Heart Failure Center Würzburg, Department of Medicine 1, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Biegus+J%22">Biegus J</searchLink>; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Collins+SP%22">Collins SP</searchLink>; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Tromp+J%22">Tromp J</searchLink>; Saw Swee Hock School of Public Health, National University of Singapore, the National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Nassif+ME%22">Nassif ME</searchLink>; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Psotka+MA%22">Psotka MA</searchLink>; Inova Heart and Vascular Institute, Falls Church, VA, USA.<br /><searchLink fieldCode="AU" term="%22Comin-Colet+J%22">Comin-Colet J</searchLink>; Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL and CIBERCV, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mentz+RJ%22">Mentz RJ</searchLink>; Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Brueckmann+M%22">Brueckmann M</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Nordaby+M%22">Nordaby M</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Ponikowski+P%22">Ponikowski P</searchLink>; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887595%22">European journal of heart failure</searchLink> [Eur J Heart Fail] 2024 Sep; Vol. 26 (9), pp. 1976-1983. <i>Date of Electronic Publication: </i>2024 Jul 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0844 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213889842%22">13889842 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Heart Fail <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38980272 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ejhf.3369 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1976 Titles: – TitleFull: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferreira JP – PersonEntity: Name: NameFull: Blatchford JP – PersonEntity: Name: NameFull: Teerlink JR – PersonEntity: Name: NameFull: Kosiborod MN – PersonEntity: Name: NameFull: Angermann CE – PersonEntity: Name: NameFull: Biegus J – PersonEntity: Name: NameFull: Collins SP – PersonEntity: Name: NameFull: Tromp J – PersonEntity: Name: NameFull: Nassif ME – PersonEntity: Name: NameFull: Psotka MA – PersonEntity: Name: NameFull: Comin-Colet J – PersonEntity: Name: NameFull: Mentz RJ – PersonEntity: Name: NameFull: Brueckmann M – PersonEntity: Name: NameFull: Nordaby M – PersonEntity: Name: NameFull: Ponikowski P – PersonEntity: Name: NameFull: Voors AA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1879-0844 Numbering: – Type: volume Value: 26 – Type: issue Value: 9 Titles: – TitleFull: European journal of heart failure Type: main |
| ResultId | 1 |